×
About 86,485 results

ALLMedicine™ Schizophrenia Center

Research & Reviews  28,200 results

Genetic regulatory and biological implications of the 10q24.32 schizophrenia risk locus.
https://doi.org/10.1093/brain/awac352
Brain : a Journal of Neurology; Wang J, Liu J et. al.

Sep 25th, 2022 - Genome-wide association studies have identified 10q24.32 as a robust schizophrenia risk locus. Here we identify a regulatory variant (rs10786700) that disrupts binding of transcription factors at 10q24.32. We independently confirmed the associatio...

The permeable boundary between biological and psychological processes in the origins of...
https://doi.org/10.1016/j.psychres.2022.114853
Psychiatry Research; Walker E

Sep 25th, 2022 - In this commentary, I describe the factors that influenced my scientific perspective and methods. Initially, the impetus for my interest in psychosis was the life story of a schizophrenia patient who was a member of a discordant monozygotic twin-p...

Association of mental disorders and psychotropic medications with bone texture as measu...
https://doi.org/10.1016/j.bone.2022.116565
Bone Hafizi S, Lix LM et. al.

Sep 25th, 2022 - Mental disorders and psychotropic medications are known to increase the risk of osteoporosis and fractures. However, current evidence is mostly limited to studies that used bone mineral density (BMD), which does not provide information about the t...

Impact of NFIB and CYP1A variants on clozapine serum concentration - a retrospective na...
https://doi.org/10.1111/cts.13422
Clinical and Translational Science; Lenk HÇ, Løvsletten Smith R et. al.

Sep 25th, 2022 - Clinical response of clozapine is closely associated with serum concentration. While tobacco smoking is the key environmental factor underlying interindividual variability in clozapine metabolism, recent genome-wide studies suggest that CYP1A and ...

Neurocognitive functioning in adult and adolescent offspring of parents with schizophre...
https://doi.org/10.1016/j.schres.2022.09.015
Schizophrenia Research; Auerbach JG, Hans SL et. al.

Sep 25th, 2022 - Neurocognitive deficits have been proposed as endophenotypes for schizophrenia. Although neurocognitive functioning has been studied extensively in first-degree relatives of schizophrenia patients at single time points, little is known about the c...

see more →

Guidelines  10 results

The American Psychiatric Association Practice Guideline for the Treatment of Patients W...
https://doi.org/10.1176/appi.ajp.2020.177901
The American Journal of Psychiatry; Keepers GA, Fochtmann LJ et. al.

Sep 2nd, 2020 - The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.|2020|Keepers GA,Fochtmann LJ,Anzia JM,Benjamin S,Lyness JM,|methods,methods,methods,classification,therapeutic use,diagnosis,therapy,

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated r...
https://doi.org/10.1177/0269881119889296
Journal of Psychopharmacology (Oxford, England); Barnes TR, Drake R et. al.

Dec 13th, 2019 - These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for schizophrenia. A consensus meeting was held in 2017, i...

EPA guidance on physical activity as a treatment for severe mental illness: a meta-revi...
https://doi.org/10.1016/j.eurpsy.2018.07.004
European Psychiatry : the Journal of the Association of E... Stubbs B, Vancampfort D et. al.

Sep 28th, 2018 - Physical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on he...

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascu...
https://doi.org/10.1177/0269881116645254
Journal of Psychopharmacology (Oxford, England); Cooper SJ, Reynolds GP et. al.

May 6th, 2016 - Excess deaths from cardiovascular disease are a major contributor to the significant reduction in life expectancy experienced by people with schizophrenia. Important risk factors in this are smoking, alcohol misuse, excessive weight gain and diabe...

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biologica...
https://doi.org/10.3109/15622975.2012.696143
The World Journal of Biological Psychiatry : the Official... Hasan A, Falkai P et. al.

Jul 28th, 2012 - These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaini...

see more →

Drugs  1,002 results see all →

Clinicaltrials.gov  2,974 results

Inpatient Evaluation of Adults With Schizophrenia
https://clinicaltrials.gov/ct2/show/NCT00001247

Sep 23rd, 2022 - Objectives: Schizophrenia and related psychoses are chronic brain disorders whose prognosis is often poor and whose pathophysiology remains obscure. Neuroimaging technologies such as PET (positron emission tomography), fMRI (functional magnetic re...

Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
https://clinicaltrials.gov/ct2/show/NCT00001246

Sep 23rd, 2022 - Objective: Our work is driven by the core hypotheses that many of the most severe neuropsychiatric disorders of childhood onset are associated with deviations from the path of normal brain development, the neuroanatomical substrates of which can b...

A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.
https://clinicaltrials.gov/ct2/show/NCT04742413

Sep 22nd, 2022 - Study design A 12-Month observational prospective multicentre cohort study based on existing and newly collected data of schizophrenia patients followed-up for one year in secondary care settings (psychiatric services). Patients will be selected b...

Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial
https://clinicaltrials.gov/ct2/show/NCT04173572

Sep 22nd, 2022 - Overview of Procedures: The PACE-Life Group will be integrated into the Schizophrenia Treatment and Evaluation Program (STEP) outpatient clinics in Raleigh, NC and Carrboro, NC. The group walks will occur on a secure online platform (Zoom). Goal-s...

Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia
https://clinicaltrials.gov/ct2/show/NCT05282329

Sep 22nd, 2022 - This is a randomized, double-blind, sham-controlled study to detect the effect of tACS for treatment of refractory auditory hallucinations in schizophrenia. 66 participants were randomly assigned 1:1 to tACS group or sham-control group. For both a...

see more →

News  2,395 results

Schizophrenia, Postmodernism: A Philosophical Treatment Exercise
https://www.medscape.com/viewarticle/981529

Sep 27th, 2022 - Schizophrenia is defined as having episodes of psychosis: periods of time when one suffers from delusions, hallucinations, disorganized behaviors, disorganized speech, and negative symptoms. The concept of schizophrenia can be simplified as a deta...

Toward a New Open-Door Model for Psychiatric Wards
https://www.medscape.com/viewarticle/981154

Sep 21st, 2022 - If isolated, patients with mental disorders may end up having higher levels of social impairment. This has led several hospitals in Spain to set up open-door departments that are more accessible. The purpose of the open-door model is to help remov...

Pediatric atopic dermatitis and neuropsychiatric disorders: What is the link?
https://www.mdedge.com/dermatology/article/258037/atopic-dermatitis/pediatric-atopic-dermatitis-and-neuropsychiatric

Sep 19th, 2022 - Key clinical point: Atopic dermatitis (AD) did not increase the incidence risk for most neuropsychiatric disorders in a pediatric cohort. Major finding: The risks for attention deficit hyperactivity disorder (hazard ratio [HR] 1.

Sound Sick? New AI Technology Might Tell If It's COVID
https://www.medscape.com/viewarticle/981035

Sep 19th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Imagine this: You think you might have COVID. You speak a couple of sentences into your phone. Then an app gives you reliable results in under a m...

Schizophrenia and postmodernism: A philosophical exercise in treatment
https://www.mdedge.com/psychiatry/article/257881/schizophrenia-other-psychotic-disorders/schizophrenia-and-postmodernism
Nicolas Badre, MD, Vladimir Khalafian, MD

Sep 15th, 2022 - Schizophrenia is defined as having episodes of psychosis: periods of time when one suffers from delusions, hallucinations, disorganized behaviors, disorganized speech, and negative symptoms. The concept of schizophrenia can be simplified as a deta.

see more →

Patient Education  13 results see all →